ARTICLE | Clinical News
Excelimmune preclinical data
September 27, 2010 7:00 AM UTC
In mice, Excelimmune's human recombinant polyclonal antibody (HRPA) against MRSA produced 100% survival against doses of S. aureus that were 100% lethal in untreated control mice. The HRPA therapy con...